Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?

Rheumatology international - 1 Sept 2014

Perez-Alamino Rodolfo, Garcia-Valladares Ignacio, Cuchacovich Raquel, Iglesias-Gamarra Antonio, Espinoza Luis R

Abstract excerpt

To determine the frequency of anticyclic citrullinated peptide (CCP) antibodies in a cohort of psoriatic arthritis (PsA) patients and to compare clinical, serological and radiological characteristics between PsA patients with and without anti-CCP antibodies. Patients with PsA, according to classification criteria for PsA, were consecutively recruited from an outpatient rheumatology clinic. Demographic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Arthritis, Psoriatic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Peptides, Cyclic

Share to Predictive Value of Tests

Share to Radiography

Share to Serologic Tests

Share to Severity of Illness Index

Source

Identifiers

PMID: 24515446
DOI: 10.1007/s00296-014-2956-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?PMID 24515446Read ↗

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.Semantic proximity Read ↗

An update on the diagnosis and management of psoriatic arthritis.Semantic proximity Read ↗

Biomarkers in psoriatic arthritis: a systematic literature review.Semantic proximity Read ↗

Recent advances in understanding and managing psoriatic arthritisSemantic proximity Read ↗

Psoriatic arthritis-new insights give new options for treatment.Semantic proximity Read ↗

Anti-Cyclic Citrullinated Peptide Antibodies in Patients with Juvenile Idiopathic ArthritisSemantic proximity Read ↗

Diagnosing psoriatic arthritis: A case report and review highlighting the role of imaging despite normal CRP valuesSemantic proximity Read ↗

Pathogenetic overview of psoriatic disease.Semantic proximity Read ↗

Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspectsSemantic proximity Read ↗

Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies.Semantic proximity Read ↗

Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic and imaging associations.Semantic proximity Read ↗

Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.